Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hematology Analyzer Evaluated for Reliability and Efficiency

By LabMedica International staff writers
Posted on 10 Dec 2012
A high throughput hematology analyzer is found to be reliable, efficient, as well as highly user-friendly and ergonomically designed. More...


A recently introduced series of hematology analyzers are able to carry out complete blood count (CBC), eight-part differential, reticulocyte and erythroblast analysis, as well as body fluids measurements (CBF).

Hematologists at St-Joseph St-Luc Hospital (Lyon, France) evaluated the Pentra DX Nexus analyzers, which offer 50 parameters and a high throughput of 120 samples per hour. The study used the XE-2100 (Sysmex; Kobe, Japan) as a reference system to compare the functions and ergonomics of the workcell. This consisted of a Pentra DX Nexus analyzer, SPS evolution slide maker/stainer and ABX Pentra ML data management system (HORIBA Medical; Northampton, UK).

The results of the evaluations show the instrument’s performance to be very good and the system offers significant improvements over previous generations of the Pentra analyzers for both traceability and ergonomics. The stability and precision functional evaluation of the results demonstrated that the technical abilities of the analyzer fulfilled stringent medical requirements and the manufacturer’s specifications.

A significant improvement in the new Pentra DX Nexus model is the color touch screen that uses easily identifiable icons to denote different functions of the analyzer. The virtual keyboard was found by the study participants to be more useful than a physical keyboard for entering data. Transferring data and hardware connections have also been made easier by multiple USB ports. In addition, a new laser source dissipates less heat and reduces the power requirements and noise generated by the instrument. The study found that the reduced size of the analyzer was also a positive attribute for laboratories, where space is of a premium.

Cleve Wright, General Manager of HORIBA Medical said, “With its new color touch screen and smart access to various functionalities, the Pentra Nexus is an exciting addition to our broad range of Pentra hematology analyzers. All are designed to meet our many differing customer requirements, both in the laboratory and at the point-of-care.”

Related Links:

St-Joseph St-Luc Hospital
Sysmex
HORIBA Medical



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.